Drospirenone
Adverse Effect of Oral Contraceptives, Initial Encounter
Lithuanian University of Health SciencesSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Adverse Effect of Oral Contraceptives, Initial Encounter cohort.
Same molecule, other indications
Drospirenone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →